Senzer N - Search Results

1

Effective remission induction of refractory childhood acute nonlymphocytic leukemia by VP-16-213 plus azacitidine.

Look AT, Dahl GV, Kalwinsky D, Senzer N, Mason C, Rivera G. Look AT, et al. Among authors: senzer n. Cancer Treat Rep. 1981 Nov-Dec;65(11-12):995-9. Cancer Treat Rep. 1981. PMID: 6170431 Clinical Trial.

2

Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.

Pratt CB, Hayes A, Green AA, Evans WE, Senzer N, Howarth CB, Ransom JL, Crom W. Pratt CB, et al. Among authors: senzer n. Cancer Treat Rep. 1981 Nov-Dec;65(11-12):1021-6. Cancer Treat Rep. 1981. PMID: 7197583 Clinical Trial.

3

Tetany: a complication of cis-dichlorodiammineplatinum(II) therapy.

Hayes FA, Green AA, Senzer N, Pratt CB. Hayes FA, et al. Among authors: senzer n. Cancer Treat Rep. 1979 Apr;63(4):547-8. Cancer Treat Rep. 1979. PMID: 445508 No abstract available.

4

Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin-doxorubicin.

Pratt CB, Champion JE, Senzer N, Green AA, Rao B, Douglass E, Meyer WE, Crom DB. Pratt CB, et al. Among authors: senzer n. Cancer. 1985 Oct 15;56(8):1930-3. doi: 10.1002/1097-0142(19851015)56:8<1930::aid-cncr2820560806>3.0.co;2-u. Cancer. 1985. PMID: 2992753

5

Evaluation of a chemotherapeutic regimen for primary liver cancer in children.

Senzer NN, Terrell W, Pratt CB. Senzer NN, et al. Cancer Treat Rep. 1978 Sep;62(9):1403-4. Cancer Treat Rep. 1978. PMID: 210945 No abstract available.

6

Cisplatin disposition in children and adolescents with cancer.

Crom WR, Evans WE, Pratt CB, Senzer N, Denison M, Green AA, Hayes FA, Yee GC. Crom WR, et al. Among authors: senzer n. Cancer Chemother Pharmacol. 1981;6(1):95-9. doi: 10.1007/BF00253017. Cancer Chemother Pharmacol. 1981. PMID: 7196807 Clinical Trial.

7

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma.

Eager RM, Cunningham CC, Senzer NN, Stephenson J Jr, Anthony SP, O'Day SJ, Frenette G, Pavlick AC, Jones B, Uprichard M, Nemunaitis J. Eager RM, et al. Among authors: senzer nn. BMC Cancer. 2009 Jul 30;9:263. doi: 10.1186/1471-2407-9-263. BMC Cancer. 2009. PMID: 19643020 Free PMC article. Clinical Trial.

8

A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours.

Bowles DW, Ma WW, Senzer N, Brahmer JR, Adjei AA, Davies M, Lazar AJ, Vo A, Peterson S, Walker L, Hausman D, Rudin CM, Jimeno A. Bowles DW, et al. Among authors: senzer n. Br J Cancer. 2013 Sep 3;109(5):1085-92. doi: 10.1038/bjc.2013.474. Epub 2013 Aug 13. Br J Cancer. 2013. PMID: 23942080 Free PMC article. Clinical Trial.

9

Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities.

Messersmith WA, Laheru DA, Senzer NN, Donehower RC, Grouleff P, Rogers T, Kelley SK, Ramies DA, Lum BL, Hidalgo M. Messersmith WA, et al. Among authors: senzer nn. Clin Cancer Res. 2004 Oct 1;10(19):6522-7. doi: 10.1158/1078-0432.CCR-04-0746. Clin Cancer Res. 2004. PMID: 15475439 Clinical Trial.

10

Phase I study of CT-2103, a polymer-conjugated paclitaxel, and carboplatin in patients with advanced solid tumors.

Nemunaitis J, Cunningham C, Senzer N, Gray M, Oldham F, Pippen J, Mennel R, Eisenfeld A. Nemunaitis J, et al. Among authors: senzer n. Cancer Invest. 2005;23(8):671-6. doi: 10.1080/07357900500359935. Cancer Invest. 2005. PMID: 16377585 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters